Tag
NASDAQ: BNTX
BioNTech and Bristol Myers report 36.7% response in lung-cancer trial
Adrian Kessler · Oct 25, 2026
Lung cancer innovations showcased at ASCO 2026 as researchers pursue earlier detection
Joseph Morton · Jun 10, 2026